| Biomarkers for early detection of acute kidney injury MS Rizvi, KB Kashani The Journal of Applied Laboratory Medicine 2 (3), 386-399, 2017 | 66 | 2017 |
| Trends in use of midodrine in the ICU: a single-center retrospective case series MS Rizvi, V Trivedi, F Nasim, E Lin, R Kashyap, N Andrijasevic, O Gajic Critical care medicine 46 (7), e628-e633, 2018 | 37 | 2018 |
| Continuation of newly initiated midodrine therapy after intensive care and hospital discharge: a single-center retrospective study MS Rizvi, AM Nei, O Gajic, KC Mara, EF Barreto Critical care medicine 47 (8), e648-e653, 2019 | 30 | 2019 |
| New decade, old debate: blocking the cytokine pathways in infection-induced cytokine cascade MS Rizvi, AG De Moraes Critical Care Explorations 3 (3), e0364, 2021 | 20 | 2021 |
| What are we doing? A survey of United States nephrology fellowship program directors SE Liebman, CA Moore, RD Monk, MS Rizvi Clinical Journal of the American Society of Nephrology 12 (3), 518-523, 2017 | 14 | 2017 |
| Oral midodrine administration during the first 24 hours of sepsis to reduce the need of vasoactive agents: placebo-controlled feasibility clinical trial A Lal, V Trivedi, MS Rizvi, A Amsbaugh, MK Myers, K Saleh, R Kashyap, ... Critical Care Explorations 3 (5), e0382, 2021 | 10 | 2021 |
| Severe Babesia microti infection presenting as multiorgan failure in an immunocompetent host JG Ripoll, MS Rizvi, RL King, CE Daniels Case Reports 2018, bcr-2018-224647, 2018 | 9 | 2018 |
| 691: High-grade babesiosis requiring red blood cell exchange therapy C Breighner, XF Fuentes, M Rizvi, J Hyder Critical Care Medicine 46 (1), 332, 2018 | 1 | 2018 |
| 152: TRENDS IN OFF-LABEL MIDODRINE USE IN MEDICAL AND SURGICAL CRITICALLY ILL PATIENTS F Nasim, M Rizvi, E Lin, V Trivedi, O Gajic Critical Care Medicine 46 (1), 59, 2018 | 1 | 2018 |
| 617: AN UNUSUAL CASE OF FULMINANT HEMORRHAGIC VARICELLA INFECTION IN AN IMMUNOCOMPETENT PATIENT A D’Souza, Z Baig, M Rizvi Critical Care Medicine 52 (1), S282, 2024 | | 2024 |
| 1216: Oral Midodrine in the First 24 Hours of Sepsis to Reduce Need for Vasoactive Agents: Clinical Trial A Lal, V Trivedi, M Rizvi, A Amsbaugh, M Myers, K Saleh, R Kashyap, ... Critical Care Medicine 49 (1), 612, 2021 | | 2021 |
| Midodrine Helps Early Discharge of Patients From the ICU, Though Results in Higher Rate of Natural Death reply MS Rizvi, AM Nei, O Gajic, EF Barreto CRITICAL CARE MEDICINE 48 (1), E79-E80, 2020 | | 2020 |
| Continuation of Newly Initiated Midodrine Therapy: Appropriate in Patients With Heart Failure? reply MS Rizvi, O Gajic, AM Nei, EF Barreto CRITICAL CARE MEDICINE 47 (10), E845-E846, 2019 | | 2019 |
| MEASURING THE IMPACT OF MICU ROUNDING PRACTICES ON TRAINEE LEARNING EXPERIENCE: A QUALITATIVE NEEDS ASSESSMENT C Wang, Z Zhang, C Breighner, M Rizvi, A Niven Chest 154 (4), 558A, 2018 | | 2018 |
| 34: EFFICACY AND SAFETY OF MIDODRINE IN CRITICALLY ILL PATIENTS M Rizvi, V Trivedi, F Nasim, E Lin, O Gajic Critical Care Medicine 46 (1), 17, 2018 | | 2018 |
| 613: AN UNUSUAL CASE OF NONTUBERCULOUS MYCOBACTERIAL BLOODSTREAM INFECTION IN AN IMMUNOCOMPETENT PATIENT M Rizvi, A Narayan, C Breighner, J Jensen Critical Care Medicine 46 (1), 293, 2018 | | 2018 |
| Follow-Up Incidence, Outcome, and Trend of ARDS in Critically Ill Patients Over 6 Years: A Population-Based Study A Joseph, T Singh, M Rizvi, XF Fuentes, JO Horo, R Cartin-Ceba, O Gajic, ... Chest 152 (4), A212, 2017 | | 2017 |
| Hemorrhage In Posterior Reversible Encephalopathy Syndrome As A Complication Of Tacrolimus Therapy MS Rizvi, PD Scanlon A58. CRITICAL CARE CASE REPORTS: NEURO-CRITICAL CARE, A1995-A1995, 2017 | | 2017 |
| Pulmonary Alveolar Proteinosis And Disseminated Mycobacteriosis: A Terminal Complication Of Myelodysplastic Syndrome MS Rizvi, PD Scanlon C44. IMMUNODEFICIENCY: CASE REPORTS, A5590-A5590, 2017 | | 2017 |
| Pulmonary Renal Syndrome With Anca Negative Pauci-Immune Glomerulonephritis In A Patient With Monoclonal Gammopathy MS Rizvi, PD Scanlon A39. AUTOIMMUNE LUNG DISEASE: CASE REPORTS, A1457-A1457, 2017 | | 2017 |
